IMMR Q3 2025 Earnings Strong EPS Beat Driven by Licensing and Royalty Revenue Tyra Biosciences Inc TYRA Q1 2026 Earnings WiderThanExpected Loss as Clinical Pipeline Progress Continues AIG Q1 2026 Earnings Strong Earnings Beat Amid Market Caution Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Pipeline Development RGA Q1 2026 Earnings Strong EPS Beat Driven by Favorable Underwriting Results Century Casinos CNTY Climbs 382 as Stock Approaches Key Resistance Level Citius Pharmaceuticals CTXR Holds Near Support as Selling Pressure Eases Chemed Corp CHE Holds Steady Near Support Amid Narrow Trading Range Uxin Limited UXIN Faces Resistance at 226 as Shares Slip 227 Cytek Biosciences Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment